Chembio Diagnostics
Manufacturing · New York, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
555 Wireless Blvd, Hauppauge, New York, ...Phone Number
(631) 924-1135Website
www.chembio.comRevenue
$55.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Chembio Diagnostics
Chembio Diagnostics, Inc., together with its subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The companys products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV 1/2 Assay Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a DPP HIV-Syphilis multiplex test for the detection of antibodies to HIV and syphilis; and a test for the detection of Hepatitis-C. Chembio Diagnostics, Inc. sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaborationRead more
Chembio Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chembio Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Chembio Diagnostics recently announced quarterly report
Funding: Get notified immidiatlly once Chembio Diagnostics has new funding data
Product Launch: Get notified when Chembio Diagnostics launches new products
Click to see if Chembio Diagnostics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Chembio Diagnostics
Check if Chembio Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Chembio Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Chembio Diagnostics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Chembio Diagnostics as Masked Content
Find more new buyers
Compare Similar Companies to Chembio Diagnostics
Compare insights from companies similar to Chembio Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Chembio Diagnostics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Chembio Diagnostics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Chembio Diagnostics.
Chembio Diagnostics financials insights
Gather financial insights about Chembio Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$31M
Chembio Diagnostics Tech Stack
A closer look at the technologies used by Chembio Diagnostics
Most Recent Scoops
Promotion
Executive Move
Chembio Diagnostics has announced that Atif Rizvi has been promoted to the role of Chief Financial Officer.
Left Company
Executive Move
Event
will be attending the Medlab Middle East 2023 conference as an exhibitor. The event will occur from February 6 to February 9, 2023.
Mergers & Acquisitions (M&A)
New Hire
Executive Move
Chembio Diagnostics News & Media
Test maker tries again to win shareholder approval for a merger - Newsday
The Medford-based manufacturer of rapid tests hasn't been able to muster the 50.1% of shares needed to complete its merger with a French firm.Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
STRASBOURG, France, April 13, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project Merci Merger Sub, Inc. (“Purchaser”), a Nevada corporation and its wholly-owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the issued and outstanding shares of common stock (the “Shares”) of Chembio Diagnostics, Inc. (NasdBiosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
STRASBOURG, France, March 29, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project Merci Merger Sub, Inc. (“Purchaser”), a Nevada corporation and its wholly-owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the issued and outstanding shares of common stock (the “Shares”) of Chembio Diagnostics, Inc. (NasdChembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System
MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the DPP HIV-Syphilis System.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chembio Diagnostics
Sign Up For FreeTo access detailed company insights
Chembio Diagnostics, Inc., together with its subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The companys products include lateral flow rapid HIV tests and Du... Read More
